HOME >> MEDICINE >> NEWS
Mood elevating hormone may trigger depression and heart problems

New Haven, Conn.--Impaired function of a receptor that regulates release of a mood elevating hormone in the brain may be responsible for causing depression, anxiety and cardiovascular disorders, according to a Yale study in Pharmacogenetics and Genomics.

The genetic variant that causes this malfunction is nearly 15 times as prevalent in African-Americans as Caucasians and might explain why African-Americans have a higher rate of congestive heart failure, according to the first author, Alexander Neumeister, M.D., associate professor in the Department of Psychiatry at Yale School of Medicine.

In his study of 29 healthy African-Americans, 11 had the genetic variant, nine were carriers of the genetic variant, and nine were not carriers. Those who tested positive for the genetic variant had elevated norepinephrine levels, heart rate and blood pressure, suggesting impaired receptor function. The effects were more pronounced after the subjects were given a medication that blocked the action of the receptor, causing a sustained release of norepinephrine.

"The subjects had a higher blood pressure response and a higher heart rate," Neumeister said. "They were perfectly normal people, but at baseline and when injected with a medication to block the receptor their test results indicated they might be at higher risk for hypertension. They also were more anxious than people without this genetic variant."

The key regulator of norepinephrine function is the alpha-2 receptor. When norepinephrine is released, it binds to this receptor, sending out a signal to block the release of norepinephrine.


'"/>

Contact: Jacqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
4-Mar-2005


Page: 1

Related medicine news :

1. Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women
2. The history and controversy behind post-menopausal hormone therapy
3. Female sex hormones play a vital role in defense against sexually transmitted diseases
4. Sex hormone metabolite reduces stress, anxiety in female rats
5. New study finds kelp can reduce level of hormone related to breast cancer risk
6. Combining hormones with external, internal radiation helps high risk prostate cancer patients
7. Sleep duration affects appetite-regulating hormones
8. Abdominal fat decreases, insulin action improves when elderly take hormone
9. New insights into hormone therapy highlight when estrogen best aids brain
10. Gender and sex hormones affect the brains pain response and more, according to new studies
11. Teenage hormone therapy to reduce adult height of tall girls linked to reduced fertility

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2020)... LOS ANGELES (PRWEB) , ... February 28, 2020 ... ... behind the liver-boosting shot, Morning Recovery, launches a new product, Liquid Focus ... to help sharpen the mind, provide steady energy, and ease stress. , ...
(Date:2/28/2020)... ... 28, 2020 , ... Attainia , the market leader ... Attainia’s new equipment planning solution to manage their fast growing, high-volume medical equipment ... to have Sovereign Healthcare use Attainia as an essential tool in the planning ...
(Date:2/28/2020)... ... February 28, 2020 , ... BenefitScape, a leader in ... of New Jersey in connection with new legislation called the New Jersey Health ... resident must either obtain health insurance, have a valid exemption, or pay a ...
(Date:2/26/2020)... ... 26, 2020 , ... Announcement Key Points: , Hera and ... company) which is best known for its commercialization of the piggyBac® transposase ... is truly dimeric and demonstrates high fidelity with no detectable off-targets while maintaining ...
(Date:2/26/2020)... ... February 26, 2020 , ... Join the live webinar ... Ionescu-Zanetti, PhD, Chief Technology Officer, Fluxion Biosciences as he provides an overview of ... for high-sensitivity circulating tumor cell (CTC) enrichment and recovery from blood samples, including ...
Breaking Medicine News(10 mins):
(Date:2/19/2020)... DURHAM, N.C. (PRWEB) , ... February 19, 2020 , ... ... illustrate the presence of oxygen-deprived clusters throughout the damaged site of a compressed spinal ... the use of a viral vector to target the oxygen-deprived sites enhances the injured ...
(Date:2/19/2020)... ... February 19, 2020 , ... ... and skilled nursing facility rehospitalization rate are the lowest in the company’s history. ... a 29 percent drop year over year. GHC’s skilled nursing facility (SNF) rehospitalization ...
(Date:2/19/2020)... ... February 19, 2020 , ... Cancer ... Molecular diagnostics platforms are increasingly becoming popular as they enable accurate diagnosis as ... market for molecular cancer diagnostics, including histology and assays, reached $1.6 billion, increasing ...
Breaking Medicine Technology:
Cached News: